Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo

Claus G. Roehrborn, Peter Boyle, Donald Bergner, Todd Gray, Marc Gittelman, Thomas Shown, Arnold Melman, R. Bruce Bracken, Ralph De Vere White, Alice Taylor, Daniel Wang, Joanne Waldstreicher

Research output: Contribution to journalArticle

174 Scopus citations

Fingerprint Dive into the research topics of 'Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo'. Together they form a unique fingerprint.

Medicine & Life Sciences